Leonard Michael J reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc reported that SVP, CIO & Head of Protein Fortification Michael J. Leonard received a grant of 34.444 phantom stock units on July 15, 2026 under a Non-Qualified Deferred Compensation Plan, based on a $99.17 closing share price. Each unit represents the right to receive one share of common stock, bringing his phantom stock balance to 1,753.290 units. This is a compensation award, not an open-market purchase.
Dimensional Fund Advisors LP, a Delaware limited partnership and registered investment adviser, reports beneficial ownership of 3,357,266 shares of Ingredion Inc common stock as of 06/30/2026. This represents 5.3% of the class. Dimensional has sole voting power over 3,291,858 shares and sole dispositive power over 3,357,266 shares, with no shared voting or dispositive power. The shares are held by underlying funds and accounts for which Dimensional or its subsidiaries serve as adviser or sub-adviser, and Dimensional disclaims beneficial ownership beyond what may be deemed under Section 13(d). No individual fund’s interest exceeds 5% of the class.
Ingredion Incorporated provided an update on its planned all-cash acquisition of the entire issued and to be issued ordinary share capital of Tate & Lyle PLC. Tate & Lyle has published a Scheme Document under UK law, explaining the court-sanctioned scheme of arrangement that will be used to implement the deal.
Tate & Lyle will send this document to its shareholders ahead of a Court Meeting and a General Meeting scheduled for July 28, 2026, where shareholders will vote on the scheme and related resolutions. The disclosure emphasizes that this is not an offer or solicitation in itself and that shareholders should base any voting decisions solely on the information in the Scheme Document.
Escoe T. Kenneth reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc director T. Kenneth Escoe received a grant of 1,516 restricted stock units as part of the company’s outside director annual equity retainer. The RSUs, which may be settled in one share of common stock each, are valued at $98.97 per unit and will vest on May 19, 2027, aligning compensation with the annual stockholder meeting cycle.
Ingredion Inc director T. Kenneth Escoe has filed an initial insider ownership report on Form 3. This filing identifies him as a director and a reporting person subject to insider disclosure rules. The report does not list any specific share holdings or recent transactions.
Magro Charles V. reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc director Charles V. Magro reported a compensation-related grant of 265 phantom stock units on June 30, 2026. The units were allocated in lieu of a cash retainer under the company’s Non-Qualified Deferred Compensation Plan, using the closing price of $94.71 per share that day.
Each phantom stock unit represents the right to receive one share of Ingredion common stock in the future. Following this award, Magro holds a total of 500 phantom stock units directly, reflecting deferred, non-cash compensation rather than an open-market purchase.
Seip David Eric reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc reported that SVP, Global Operations and CSCO David Eric Seip received a grant of phantom stock as part of his compensation. On June 30, 2026, he was awarded 18.44 phantom stock units, valued using the $94.711 closing price of Ingredion common stock that day.
Each phantom stock unit represents the right to receive one share of common stock under the company’s Non-Qualified Deferred Compensation Plan. Following this award, Seip holds a total of 13,236.1041 phantom stock units, reflecting his accumulated deferred compensation position rather than an open-market stock purchase or sale.
Leonard Michael J reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president Michael J. Leonard reported a compensation-related award of phantom stock units. On June 30, 2026, he was granted 36.066 phantom stock units based on a closing common share price of $94.71, increasing his total phantom stock holdings to 1,718.846 units. Each phantom stock unit represents the right to receive one share of Ingredion common stock under the company’s Non-Qualified Deferred Compensation Plan, so this filing reflects deferred equity-based compensation rather than an open-market stock purchase or sale.
Ingredion Incorporated has completed the previously announced sale of 51% of the issued share capital of Rafhan Maize Products Co. Ltd. to a purchaser group led by Nishat Hotels and Properties Limited for approximately $165 million in cash, received in U.S. dollars.
Rafhan Maize generated about $250 million of net sales in 2025 and is not in a reportable segment. As part of the deal, the purchasers acquired roughly 78% of Rafhan Maize’s outstanding shares, while Ingredion retained an approximate 20% minority ownership interest. A shareholders agreement grants Ingredion a put option exercisable beginning in the fifth year after closing, and new manufacturing, supply, and distribution agreements will support ongoing product flows between Ingredion and Rafhan Maize.
Ingredion Incorporated entered into a new senior unsecured delayed draw term loan facility totaling $1,475,000,000 to help finance its planned acquisition of Tate & Lyle PLC, refinance certain Tate & Lyle debt, and pay related fees and expenses.
The facility is split into a $500,000,000 Tranche A-1 maturing three years after funding and a $975,000,000 Tranche B-1 maturing five years after funding, each amortizing at 5% per year in quarterly payments. Interest is based on a base rate or SOFR plus margins linked to Ingredion’s credit ratings or leverage ratio.
The agreement includes financial covenants requiring a maximum leverage ratio of 3.5 to 1.0, with a temporary step-up to 4.0 to 1.0 after a material acquisition, and a minimum interest coverage ratio of 3.5 to 1.0. The new facility replaces in full the $1,475,000,000 tranche A commitment under Ingredion’s existing $4,225,000,000 bridge loan, leaving the $2,750,000,000 tranche B bridge commitment outstanding.